1: Koller A, Rid R, Beyreis M, Bianchini R, Holub BS, Lang A, Locker F, Brodowicz B, Velickovic O, Jakab M, Kerschbaum H, Önder K, Kofler B. In vitro toxicity of the galanin receptor 3 antagonist SNAP 37889. Neuropeptides. 2016 Apr;56:83-8. doi: 10.1016/j.npep.2015.12.003. doi: 10.1016/j.regpep.2010.08.009. doi: 10.1016/j.mex.2014.09.003. 5: Kothandan G, Gadhe CG, Cho SJ. Theoretical characterization of galanin receptor type 3 (Gal3 ) and its interaction with agonist (GALANIN) and antagonists (SNAP 37889 and SNAP 398299): an in silico analysis. Chem Biol Drug Des. 2013 Jun;81(6):757-74. doi: 10.1111/cbdd.12128. Erratum in: Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14978. Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5632. 7: Barreto SG, Bazargan M, Zotti M, Hussey DJ, Sukocheva OA, Peiris H, Leong M, Keating DJ, Schloithe AC, Carati CJ, Smith C, Toouli J, Saccone GT. Galanin receptor 3--a potential target for acute pancreatitis therapy. Neurogastroenterol Motil. 2011 Mar;23(3):e141-51. doi: 10.1111/j.1365-2982.2010.01662.x. doi: 10.1111/exd.12067. doi: 10.1111/j.1369-1600.2011.00360.x.